Procaps Group, S.A Price to Sales Ratio 2020-2023 | PROCF

Historical PS ratio values for Procaps Group, S.A (PROCF) over the last 10 years. The current P/S ratio for Procaps Group, S.A as of February 07, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Procaps Group, S.A P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-02-03 1.01 0.25
2023-09-30 3.62 $4.10 0.88
2023-03-31 4.51 $4.04 1.12
2022-12-31 5.25 $4.05 1.29
2022-09-30 7.00 $4.34 1.61
2022-06-30 9.32 $4.35 2.14
2022-03-31 8.50 $4.32 1.97
2021-12-31 9.75 $4.50 2.17
2021-09-30 10.20 $4.00 2.55
2023-06-30 4.30 $53.34 0.08
2021-06-30 10.09 $52.25 0.19
2021-03-31 10.05 $51.23 0.20
2020-12-31 10.40 $50.43 0.21
2020-09-30 9.93 0 0.00
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49